Hypoxia-inducible factor 1: A link between metabolism and T cell differentiation and a potential therapeutic target

OncoImmunology

Volumn 1, Issue 4, 2012, Pages 510-515

  Pan, Fan ^a   Barbi, Joseph ^a   Pardoll, Drew M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cancer; Hif1; Hypoxia; Inflammation; Metabolism; T cell differentiation

Indexed keywords

GAMMA INTERFERON; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN;

ARTICLE; AUTOIMMUNE DISEASE; CANCER THERAPY; CELL FATE; CELL LINEAGE; CELL METABOLISM; CELLULAR IMMUNITY; GENE; HYPOXIA INDUCIBLE FACTOR 1 ALPHA GENE; INFLAMMATORY DISEASE; LYMPHOCYTE DIFFERENTIATION; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN TARGETING; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TH17 CELL;

EID: 84878999668     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.19457     Document Type: Article

References (24)

1. + T cell lineage differentiation. Immunity 2009; 30:646-55; http://dx.doi.org/10.1016/j.immuni.2009.05.001
2. Dong C. Genetic controls of Th17 cell differentiation and plasticity. Exp Mol Med 2011; 43:1-6; http://dx.doi.org/10.3858/emm.2011.43.1.007
3. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008; 133:775-87; http://dx.doi.org/10.1016/j.cell.2008.05.009
4. Littman DR, Rudensky AY. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 2010; 140:845-58; http://dx.doi.org/10.1016/j.cell.2010.02.021
5. Delgoffe GM, Powell JD. mTOR: taking cues from the immune microenvironment. Immunology 2009; 127: 459-65; http://dx.doi.org/10.1111/j.1365-2567.2009.03125.x
6. Powell JD, Delgoffe GM. The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity 2010; 33:301-11; http://dx.doi.org/10.1016/j.immuni.2010.09.002
7. Delgoffe GM, Pollizzi KN, Waickman AT, Heikamp E, Meyers DJ, Horton MR, et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol 2011; 12:295-303; http://dx.doi.org/10.1038/ni.2005
8. Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 2011; 208: 1367-76; http://dx.doi.org/10.1084/jem.20110278
9. Semenza GL. Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev 1998; 8:588-94; http://dx.doi.org/10.1016/S0959-437X(98)80016-6
10. Zarember KA, Malech HL. HIF-1alpha: a master regulator of innate host defenses? J Clin Invest 2005; 115:1702-4; http://dx.doi.org/10.1172/JCI25740
11. Imtiyaz HZ, Simon MC. Hypoxia-inducible factors as essential regulators of inflammation. Curr Top Microbiol Immunol 2010; 345:105-20; http://dx.doi.org/10.1007/82_2010_74
12. Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y, et al. Control of T(H)17/T(reg) balance by hypoxiainducible factor 1. Cell 2011; 146:772-84; http://dx.doi.org/10.1016/j.cell.2011.07.033
13. Kryczek I, Zhao E, Liu Y, Wang Y, Vatan L, Szeliga W, et al. Human TH17 Cells Are Long-Lived Effector Memory Cells. Sci Transl Med 2011; 3104ra110.
14. Semenza GL. HIF-1 inhibitors for cancer therapy: from gene expression to drug discovery. Curr Pharm Des 2009; 15:3839-43; http://dx.doi.org/10.2174/138161209789649402
15. Zhang H, Qian DZ, Tan YS, Lee K, Gao P, Ren YR, et al. Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth. Proc Natl Acad Sci U S A 2008; 105:19579-86; http://dx.doi.org/10.1073/pnas.0809763105
16. Huh JR, Leung MW, Huang P, Ryan DA, Krout MR, Malapaka RR, et al. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORct activity. Nature 2011; 472:486-90; http://dx.doi.org/10.1038/nature09978
17. Korn T, Reddy J, Gao W, Bettelli E, Awasthi A, Petersen TR, et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 2007; 13:423-31; http://dx.doi.org/10.1038/nm1564
18. Nishikawa H, Sakaguchi S. Regulatory T cells in tumor immunity. Int J Cancer 2010; 127:759-67;
19. Martin-Orozco N, Muranski P, Chung Y, Yang XO, Yamazaki T, Lu S, et al. T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 2009; 31:787-98; http://dx.doi.org/10.1016/j.immuni.2009.09.014
20. Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med 2009; 206: 1457-64; http://dx.doi.org/10.1084/jem.20090207
21. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009; 15:1016-22; http://dx.doi.org/10.1038/nm.2015
22. + Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer. Oncol Rep 2011; 25:1271-7
23. Hot A, Miossec P. Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes. Ann Rheum Dis 2011; 70:727-32; http://dx.doi.org/10.1136/ard.2010.143768
24. Li J, Lau GK, Chen L, Dong SS, Lan HY, Huang XR, et al. Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. PLoS One 2011; 6:e21816; http://dx.doi.org/10.1371/journal.pone.0021816